Arc-1 review
Wide catalogue, no entity
A longevity storefront selling sermorelin, NAD⁺, glutathione, rapamycin and per-dose compounded GLP-1s, with no company name behind any of it.
Our verdict
Arc-1 is a catalogue: sermorelin, NAD⁺, glutathione, rapamycin, metformin, enclomiphene and per-dose GLP-1s, with a $0 consultation fee and a LegitScript badge on its product pages. Breadth is the pitch, and breadth is also the problem — it discloses no legal entity, no address, no named clinician and no pharmacy partner, so for most of that menu there is nothing to verify and, in several cases, nothing much in the way of human evidence either.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
At a glance
- Category
- Peptide telehealth
- Access
- Per-dose purchases, $0 consultation fee; state list not published
- LegitScript
- Certified
- Updated
- July 2026
Popular alternative
Oak Longevity
Low-cost sermorelin within a broader longevity stack
Check Oak Longevity availability →What it is
Arc-1 is a longevity-positioned direct-to-consumer storefront selling prescription products per dose rather than by subscription. Its menu spans sermorelin, NAD⁺, glutathione, rapamycin, metformin, enclomiphene, B12 and ED medication, alongside compounded semaglutide and tirzepatide priced per strength. It advertises a $0 consultation fee, free expedited shipping, a 30-day satisfaction guarantee, and displays a LegitScript Certified badge on its product pages.
How it works
A virtual consultation gates the purchase, and a licensed clinician reviews before anything ships — but the experience is built as a checkout rather than a clinical relationship, and it shows. There is no lab work in the default path, which is worth pausing on given what is on the shelf: rapamycin and metformin are approved drugs being sold for off-label longevity use, and prescribing those without a workup is a meaningfully different proposition from prescribing a vitamin. One practical warning from our verification: although Arc-1 markets per-dose, no-subscription purchasing, its cart has shown items flagged as deferred, subscription or recurring. Read the checkout terms carefully and confirm in writing whether your order renews.
Pricing transparency
Arc-1 publishes per-dose pricing for its compounded GLP-1s, and those figures climb with strength rather than staying flat — the practical consequence being that your monthly cost rises as you titrate up. It does not publish peptide or NAD⁺ pricing in the same way, so we are not quoting a sermorelin figure. The $0 consultation fee and free shipping are real and worth something. Before ordering, settle three things: the price at the dose you would actually end up on rather than the starting dose, whether the order is one-time or recurring, and what the 30-day satisfaction guarantee covers for a prescription product that generally cannot be returned once dispensed.
Branded vs compounded
Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The compounded products are pharmacy preparations, not therapeutically equivalent to branded drugs, and no pharmacy partner is named. The menu needs unpacking by evidence tier rather than read as a single longevity stack. Sermorelin acts on the growth-hormone axis — a real mechanism with thin long-term outcome data. Injectable NAD⁺ has no controlled human outcome trials; oral NR and NMN are the studied forms and they raise blood NAD⁺ rather than a demonstrated clinical outcome. Injectable glutathione has essentially no controlled human outcome evidence for the claims made about it. Rapamycin and metformin are approved drugs — for transplant rejection and type 2 diabetes respectively — sold here off-label for longevity; rapamycin extends lifespan in mice, which is a robust animal result and not a human one, and metformin's longevity case rests on observational analyses of diabetic populations that cannot establish benefit in healthy people. Off-label prescribing is legal and often reasonable. It is not evidence of effect. Individual results vary.
Pros and watch-outs
What we like
- A genuinely broad longevity formulary in one place, priced per dose
- $0 consultation fee, free expedited shipping and a 30-day satisfaction guarantee
- LegitScript Certified badge displayed on product pages
- Per-dose GLP-1 pricing is published per strength rather than gated
- A licensed clinician reviews the virtual consultation before anything ships
Watch-outs
- No legal entity name, address, named clinician or pharmacy partner disclosed
- No state list published, so coverage is unverifiable before you start
- Checkout has shown items flagged as recurring despite the per-dose marketing
- Per-dose GLP-1 pricing climbs with strength, so cost rises as you titrate
- Rapamycin and metformin are sold off-label for longevity with no human outcome evidence
Best for
Self-directed buyers who already know which compound they want, prefer paying per dose, and are comfortable with a storefront that discloses very little about itself.
Who should look elsewhere
Anyone who wants a named company and clinician, lab-guided oversight before an off-label longevity drug, or a menu limited to compounds with human outcome data.
The evidence behind what Arc-1 prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- Sermorelin: a real GHRH drug, read against the anti-aging pitch
An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
- Glutathione: the master antioxidant, and where the evidence actually is
Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.
How Arc-1 compares
A few alternatives worth a look, depending on what you’re optimizing for.
AgelessRx
Sermorelin from a longevity-medicine practice
See AgelessRx →Defy Medical
The widest physician-supervised peptide menu with lab testing
See Defy Medical →- System Labs
NAD⁺ bundled with glutathione, B-12 and sermorelin from one service
See System Labs →
Peptides & longevity · Reviewed and last verified July 2026
How we assessed this. This review reflects Aminoscope’s own read of Arc-1’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- What does Arc-1 actually sell?
- A wide longevity catalogue: sermorelin, NAD⁺, glutathione, rapamycin, metformin, enclomiphene, B12 and ED medication, plus compounded semaglutide and tirzepatide priced per strength. Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate.
- Is Arc-1 really subscription-free?
- It markets per-dose purchasing rather than a subscription, but our verification found cart items flagged as deferred, subscription or recurring. Read the checkout terms carefully and confirm in writing whether your specific order is a one-time purchase or renews before you pay.
- How much can you verify about Arc-1?
- Very little beyond the LegitScript badge on its product pages. It discloses no legal entity name, no address, no named clinicians and no pharmacy partner, and publishes no list of the states it serves. For a company shipping compounded injectables, that is a large amount of missing information.
- Should I take rapamycin or metformin for longevity?
- Not on human evidence. Both are approved drugs for other indications — transplant rejection and type 2 diabetes — prescribed off-label here. Rapamycin extends lifespan in mice, an animal result that has not been demonstrated in people, and metformin's longevity case rests on observational data in diabetic populations. Off-label prescribing being legal is a regulatory fact, not a clinical result.